Izhar Rubina, Husain Samia, Tahir Suhaima, Husain Sonia
Department of Gynaecology and Obstetrics, Abbasi Shaheed Hospital and Karachi Medical and Dental College, Karachi, Pakistan.
Aziz Medical Center, Karachi, Pakistan.
J Reprod Infertil. 2017 Oct-Dec;18(4):361-367.
The purpose of this study was to evaluate the ability of poor ovarian response criteria to classify women presenting with infertility and oligomenorrhea as having "occult" premature ovarian insufficiency.
This was a cross sectional study conducted at Aziz Medical Center, Karachi, Pakistan from 1st August 2015 to 31st July 2016. Women with infertility and oligomenorrhea were included. All eligible women underwent day 2 FSH level and an early follicular phase transvaginal ultrasound to assess the antral follicular count (AFC). All women then underwent the confirmatory test, of Anti-Mullerian Hormone (AMH) level. The main outcome measure was assignment to occult premature ovarian insufficiency (POI) after screening that used the criteria set out in fertility guideline for predicting the likely ovarian response to gonadotrophin stimulation. Another measure was to compare the sensitivity and specificity of the two index criteria, of FSH and AFC, relative to the emerging reference standard, of the AMH criterion.
The three criteria together classified 59 (34.91%) women as occult POI in those with oligomenorrhea. The sensitivity, specificity, negative predictive value and positive predictive value of FSH relative to AMH for these women were 77.8%, 95.7%, 90.2% and 89.4%, respectively whereas the same values of AFC relative to AMH were 92.6%, 99.1 %, 96.6% and 98%, respectively.
Women with menstrual irregularity and infertility are at a higher risk for satisfying criteria of poor ovarian response irrespective of age. A policy incorporating these surrogate markers can be used to screen these women for occult premature ovarian insufficiency.
本研究的目的是评估卵巢反应不良标准将患有不孕症和月经过少的女性归类为“隐匿性”卵巢早衰的能力。
这是一项于2015年8月1日至2016年7月31日在巴基斯坦卡拉奇阿齐兹医疗中心进行的横断面研究。纳入了患有不孕症和月经过少的女性。所有符合条件的女性均在月经周期第2天检测促卵泡激素(FSH)水平,并在卵泡早期进行经阴道超声检查以评估窦卵泡计数(AFC)。然后所有女性均接受抗苗勒管激素(AMH)水平的确诊检测。主要结局指标是根据预测对促性腺激素刺激可能的卵巢反应的生育指南中规定的标准进行筛查后,将其归类为隐匿性卵巢早衰(POI)。另一项指标是比较FSH和AFC这两个指标标准相对于新出现的参考标准AMH标准的敏感性和特异性。
这三项标准共同将59名(34.91%)月经过少的女性归类为隐匿性POI。对于这些女性,FSH相对于AMH的敏感性、特异性、阴性预测值和阳性预测值分别为77.8%、95.7%、90.2%和89.4%,而AFC相对于AMH的相同值分别为92.6%、99.1%、96.6%和98%。
月经不规律和不孕的女性无论年龄大小,满足卵巢反应不良标准的风险都更高。纳入这些替代标志物的政策可用于筛查这些女性是否患有隐匿性卵巢早衰。